Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.44 |
| ▸ | RAB9A | P51151 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | NCF1 | P14598 | 3/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9302323 | 0.90 | NPC1 (0.41) | NPC1RAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL9304066 | 0.75 | ALDH1A1 (0.42) | NPC1RAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL29390450 | 0.74 | NPC1 (0.52) | NPC1RAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL902873 | 0.74 | NPC1 (0.52) | NPC1RAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL20495402 | 0.71 | ALDH1A1 (0.39) | NPC1RAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL3525605 | 0.71 | NPC1 (0.49) | NPC1RAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL21397784 | 0.70 | KMT2A (0.53) | ALDH1A1MEN1KMT2ACYP3A4TP53 | |
| SCHEMBL12533920 | 0.70 | ALDH1A1 (0.52) | NPC1RAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL12533917 | 0.70 | ALDH1A1 (0.52) | NPC1RAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL12533914 | 0.70 | ALDH1A1 (0.52) | NPC1RAB9AALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101607973-B | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC KR | 2013-06-12 | — | — | CN | disclosed |
| EP-2062958-B1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC (KR) | 2010-07-28 | — | — | EP | disclosed |
| CN-101607973-A | New organic electroluminescent compounds and use the el light emitting device of this compound | GRACEL DISPLAY INC (KR) | 2009-12-23 | — | — | CN | disclosed |
| US-20090159130-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-25 | — | — | US | disclosed |
| EP-2062958-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090159130-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | AOX1, LEF1, ODC1 | NPC1 1452/4885RAB9A 2282/4885ALDH1A1 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.